https://scholars.lib.ntu.edu.tw/handle/123456789/453072
標題: | Laminaria and sulprostone in second trimester pregnancy termination for fetal abnormalities | 作者: | Chung Y.P. HSIAO-LIN HWA TSANG-MING KO |
公開日期: | 1999 | 卷: | 65 | 期: | 1 | 起(迄)頁: | 47-52 | 來源出版物: | International Journal of Gynecology and Obstetrics | 摘要: | The efficacy and safety of intracervical placement of laminaria and intravenous prostaglandin E2 (sulprostone) infusion for termination of second-trimester pregnancies with abnormal fetuses was investigated. One hundred and six pregnant women at 13-29 weeks' gestation with fetal anomalies underwent laminaria tent insertion into the cervical canal on admission. The next morning, Sulprostone infusion was started at a rate of 16 χ/h and increased by 16 μg/h every 30 min to induce uterine contractions. Induction- to-abortion time (IAT), success and complete abortion rates, and sulprostone- related side effects were registered. The overall success and complete abortion rates within 24 h were 91.5 and 80.2%, respectively. The mean IAT was 12.1 ± 7.6 h. The incidence of nausea and/or vomiting was 17.9%, with 1.7 episodes per case. Diarrhea and fever (9.5%) were not common. Laminaria tent insertion plus sulprostone infusion was an effective and safe regimen for second-trimester termination of pregnancy with live fetuses. |
URI: | https://scholars.lib.ntu.edu.tw/handle/123456789/453072 | DOI: | 10.1016/S0020-7292(98)00219-7 | SDG/關鍵字: | prostaglandin E2; sulprostone; adult; article; clinical trial; device; dose response; drug safety; female; fetus disease; human; intramuscular drug administration; intravenous drug administration; Laminaria; major clinical study; nausea; pregnancy termination; priority journal; second trimester pregnancy; uterine cervix; uterus contraction; vomiting |
顯示於: | 法醫學科所 |
在 IR 系統中的文件,除了特別指名其著作權條款之外,均受到著作權保護,並且保留所有的權利。